Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
BIND Therapeutics
4149
BIND Therapeutics
Health Care
Technology
Biotechnology
BIND Therapeutics is a clinical-stage nanomedicine platform company developing Accurins, a class of highly selective, targeted therapeutics.
Suggest edits
Founded
2006
Raised
$37.9M
Follow us
Also headquartered in Cambridge
MIT
Raspberry Pi
ARM
Xconomy
Money Mover
Biogen
HubSpot
Formlabs
General Catalyst
Akamai
Companies in the same industry
Finch Therapeutics Group
Prevail Therapeutics
APRINOIA Therapeutics
Galecto Biotech
InSitu Biologics
Iota Biosciences
Waterstone Pharmaceuticals
H1
ResMed
Entellus Medical
Alexa global traffic share
Twitter followers
Overview
Funding
2
Add info
Add round
13 Feb
2012
$25,500,000
Venture capital (Series D)
RUSNANO
29 Jun
2010
$12,400,000
Venture capital (Series C)
Endeavour Vision
,
Flagship Ventures
,
Polaris Partners
,
+2
